SONN - Financial Reports List - Sonnet BioTherapeutics Holdings, Inc. - IntrinsicAlpha

Sonnet BioTherapeutics Holdings, Inc. SONN

Healthcare - Biotechnology - NASDAQ - US

$ 1.285

3.17 %

$ 3.94 M

Market Cap

-0.12

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2024-12-31	5268.84%	-170.49%	-122.81%
Quarterly Report	Q4	8-K	2024-09-30	180.21%	14.91%	11.85%
Annual Report	FY	10-K	2024-09-30	-87.40%	60.51%	36.95%
Quarterly Report	Q3	8-K	2024-06-30	0.00%	11.18%	9.88%
Quarterly Report	Q2	8-K	2024-03-31	0.00%	106.44%	31.71%
Quarterly Report	Q1	8-K	2023-12-31	-50.00%	78.65%	77.21%
Quarterly Report	Q4	8-K	2023-09-30	-40.63%	50.94%	51.20%
Annual Report	FY	10-K	2023-09-30	-57.76%	36.75%	36.66%
Quarterly Report	Q3	8-K	2023-06-30	-40.63%	49.96%	50.23%
Quarterly Report	Q2	8-K	2023-03-31	-61.77%	30.89%	31.00%

1